Eli Lilly and Company (LLY) vs Quhuo Limited (QH)
See how Eli Lilly and Company and Quhuo Limited differ across market data and performance, so you can decide which asset best fits your strategy.
$1,210.02
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
View Full Page$4.16
NasdaqCM
Key Metrics Comparison
Eli Lilly and CompanyLLY
Market Cap$1.079T
Price$1,210.02
24h Change-0.87%
24h Volume$2.17M
Employees50,000
Shares Outstanding944,818,881
Quhuo LimitedQH
Market Cap$365.783B
Price$4.16
24h Change-9.17%
24h Volume$15.7K
Employees474
Shares OutstandingN/A
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
LLY
74.7%QH
25.3%Volume Share
Share of combined 24h volume
LLY
99.3%QH
1.0%24h Performance
Price change over last 24 hours
LLY
-0.87%QH
-9.17%Price Comparison
Eli Lilly and Company
Quhuo Limited